US 8906853
[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
granted A61KA61K31/7056A61K31/713
Quick answer
US patent 8906853 ([N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7056, A61K31/713, A61K38/21, A61K45/06